SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA), receiving recognition from the industry organization for its work in developing and commercializing robotic surgery technology (https://nnw.fm/mXdgs). The award comes as the company’s SSi Mantra surgical robotic system continues to expand its global footprint, with more than 11,700 procedures completed and regulatory approvals in 14 countries.
The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties. The award was presented to SS Innovations after the company was selected from a field of ten finalists that included established names such as Intuitive, Johnson & Johnson MedTech, Medtronic, and others. The Surgical Robotics Industry Awards recognize one company each year in the Outstanding Company category based on criteria including commercial performance, technological innovation, societal impact, customer recognition, ethical standards, and workplace practices.
Chairman and Chief Executive Officer Dr. Sudhir Srivastava said the award reflects the company’s focus on expanding access to robotic surgery while continuing to develop technologies intended to improve affordability for hospitals and healthcare systems. The recognition coincides with continued operational growth for the SSi Mantra platform. As of June 22, 2026, surgeons had completed a cumulative 11,719 multi-specialty procedures, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. The breadth of procedures performed reflects the system’s use across multiple surgical disciplines, with physicians using the platform in more than 170 different types of surgical procedures.
Training has also expanded alongside system adoption. Approximately 2,100 physicians have completed training on the SSi Mantra platform, an important consideration for robotic surgery systems, where physician education and clinical familiarity often influence hospital purchasing decisions and long-term utilization. The company’s commercial footprint has continued to broaden internationally, with regulatory approvals granted in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates. These approvals provide opportunities for continued market expansion as healthcare systems evaluate robotic-assisted surgery across a wider range of procedures.
SS Innovations describes the SSi Mantra as a modular, multi-arm robotic surgery platform designed to support multiple surgical specialties. The system incorporates between three and five robotic arms, a three-dimensional 4K visualization system, an ergonomic surgeon console, and digital imaging capabilities that allow integration of diagnostic information during procedures. Its instrument portfolio includes more than 40 robotic surgical instruments, including smaller 5-millimeter instruments intended for pediatric and ear, nose, and throat procedures. The company has also developed a portable tele-surgeon console, known as the SSi MantrAsana, which supports remote surgical capabilities. While telesurgery remains an emerging area, SS Innovations has reported performing more than 20 cardiac telesurgeries using the platform.
For investors, the recognition provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global surgical robotics market. The award underscores the company’s progress in a field dominated by larger players, highlighting its potential to capture market share with a versatile and affordable platform.
